Report Detail

Request for Sample of this report

Chemical & Material Global Tolvaptan API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4541180
    • |
  • 19 July, 2023
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Tolvaptan API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Tolvaptan API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tolvaptan API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Tolvaptan API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Tolvaptan API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Tolvaptan API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tolvaptan API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tolvaptan API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Extrovis AG, Aurore Life Sciences Private Ltd, Lupin Ltd, Olon Spa and Alkem Laboratories Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Tolvaptan API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purityan Pharmaceutical
Nanjing Chia Tai Tianqing Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tolvaptan API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tolvaptan API, with price, sales, revenue and global market share of Tolvaptan API from 2018 to 2023.
Chapter 3, the Tolvaptan API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tolvaptan API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tolvaptan API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tolvaptan API.
Chapter 14 and 15, to describe Tolvaptan API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Tolvaptan API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tolvaptan API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tolvaptan API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Tablet
    • 1.4.3 Others
  • 1.5 Global Tolvaptan API Market Size & Forecast
    • 1.5.1 Global Tolvaptan API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Tolvaptan API Sales Quantity (2018-2029)
    • 1.5.3 Global Tolvaptan API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Extrovis AG
    • 2.1.1 Extrovis AG Details
    • 2.1.2 Extrovis AG Major Business
    • 2.1.3 Extrovis AG Tolvaptan API Product and Services
    • 2.1.4 Extrovis AG Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Extrovis AG Recent Developments/Updates
  • 2.2 Aurore Life Sciences Private Ltd
    • 2.2.1 Aurore Life Sciences Private Ltd Details
    • 2.2.2 Aurore Life Sciences Private Ltd Major Business
    • 2.2.3 Aurore Life Sciences Private Ltd Tolvaptan API Product and Services
    • 2.2.4 Aurore Life Sciences Private Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Aurore Life Sciences Private Ltd Recent Developments/Updates
  • 2.3 Lupin Ltd
    • 2.3.1 Lupin Ltd Details
    • 2.3.2 Lupin Ltd Major Business
    • 2.3.3 Lupin Ltd Tolvaptan API Product and Services
    • 2.3.4 Lupin Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Lupin Ltd Recent Developments/Updates
  • 2.4 Olon Spa
    • 2.4.1 Olon Spa Details
    • 2.4.2 Olon Spa Major Business
    • 2.4.3 Olon Spa Tolvaptan API Product and Services
    • 2.4.4 Olon Spa Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Olon Spa Recent Developments/Updates
  • 2.5 Alkem Laboratories Ltd
    • 2.5.1 Alkem Laboratories Ltd Details
    • 2.5.2 Alkem Laboratories Ltd Major Business
    • 2.5.3 Alkem Laboratories Ltd Tolvaptan API Product and Services
    • 2.5.4 Alkem Laboratories Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Alkem Laboratories Ltd Recent Developments/Updates
  • 2.6 Msn Laboratories Private Ltd
    • 2.6.1 Msn Laboratories Private Ltd Details
    • 2.6.2 Msn Laboratories Private Ltd Major Business
    • 2.6.3 Msn Laboratories Private Ltd Tolvaptan API Product and Services
    • 2.6.4 Msn Laboratories Private Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Msn Laboratories Private Ltd Recent Developments/Updates
  • 2.7 Apotex Pharmachem India Pvt Ltd
    • 2.7.1 Apotex Pharmachem India Pvt Ltd Details
    • 2.7.2 Apotex Pharmachem India Pvt Ltd Major Business
    • 2.7.3 Apotex Pharmachem India Pvt Ltd Tolvaptan API Product and Services
    • 2.7.4 Apotex Pharmachem India Pvt Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
  • 2.8 Hetero Drugs Ltd
    • 2.8.1 Hetero Drugs Ltd Details
    • 2.8.2 Hetero Drugs Ltd Major Business
    • 2.8.3 Hetero Drugs Ltd Tolvaptan API Product and Services
    • 2.8.4 Hetero Drugs Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Hetero Drugs Ltd Recent Developments/Updates
  • 2.9 Otsuka Pharmaceutical
    • 2.9.1 Otsuka Pharmaceutical Details
    • 2.9.2 Otsuka Pharmaceutical Major Business
    • 2.9.3 Otsuka Pharmaceutical Tolvaptan API Product and Services
    • 2.9.4 Otsuka Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Otsuka Pharmaceutical Recent Developments/Updates
  • 2.10 Jiangsu Hengrui Pharmaceuticals Co Ltd
    • 2.10.1 Jiangsu Hengrui Pharmaceuticals Co Ltd Details
    • 2.10.2 Jiangsu Hengrui Pharmaceuticals Co Ltd Major Business
    • 2.10.3 Jiangsu Hengrui Pharmaceuticals Co Ltd Tolvaptan API Product and Services
    • 2.10.4 Jiangsu Hengrui Pharmaceuticals Co Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Jiangsu Hengrui Pharmaceuticals Co Ltd Recent Developments/Updates
  • 2.11 Zhejiang Huahai Pharmaceutical Co Ltd
    • 2.11.1 Zhejiang Huahai Pharmaceutical Co Ltd Details
    • 2.11.2 Zhejiang Huahai Pharmaceutical Co Ltd Major Business
    • 2.11.3 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Product and Services
    • 2.11.4 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
  • 2.12 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical
    • 2.12.1 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Details
    • 2.12.2 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Major Business
    • 2.12.3 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Product and Services
    • 2.12.4 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Recent Developments/Updates
  • 2.13 Chengdu Baiyu Pharmaceutical
    • 2.13.1 Chengdu Baiyu Pharmaceutical Details
    • 2.13.2 Chengdu Baiyu Pharmaceutical Major Business
    • 2.13.3 Chengdu Baiyu Pharmaceutical Tolvaptan API Product and Services
    • 2.13.4 Chengdu Baiyu Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
  • 2.14 Sichuan Ren'an Pharmaceutical
    • 2.14.1 Sichuan Ren'an Pharmaceutical Details
    • 2.14.2 Sichuan Ren'an Pharmaceutical Major Business
    • 2.14.3 Sichuan Ren'an Pharmaceutical Tolvaptan API Product and Services
    • 2.14.4 Sichuan Ren'an Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Sichuan Ren'an Pharmaceutical Recent Developments/Updates
  • 2.15 Nanjing Chia Tai Tianqing Pharmaceutical
    • 2.15.1 Nanjing Chia Tai Tianqing Pharmaceutical Details
    • 2.15.2 Nanjing Chia Tai Tianqing Pharmaceutical Major Business
    • 2.15.3 Nanjing Chia Tai Tianqing Pharmaceutical Tolvaptan API Product and Services
    • 2.15.4 Nanjing Chia Tai Tianqing Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Tolvaptan API by Manufacturer

  • 3.1 Global Tolvaptan API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Tolvaptan API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Tolvaptan API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Tolvaptan API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Tolvaptan API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Tolvaptan API Manufacturer Market Share in 2022
  • 3.5 Tolvaptan API Market: Overall Company Footprint Analysis
    • 3.5.1 Tolvaptan API Market: Region Footprint
    • 3.5.2 Tolvaptan API Market: Company Product Type Footprint
    • 3.5.3 Tolvaptan API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tolvaptan API Market Size by Region
    • 4.1.1 Global Tolvaptan API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Tolvaptan API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Tolvaptan API Average Price by Region (2018-2029)
  • 4.2 North America Tolvaptan API Consumption Value (2018-2029)
  • 4.3 Europe Tolvaptan API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Tolvaptan API Consumption Value (2018-2029)
  • 4.5 South America Tolvaptan API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Tolvaptan API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Tolvaptan API Sales Quantity by Type (2018-2029)
  • 5.2 Global Tolvaptan API Consumption Value by Type (2018-2029)
  • 5.3 Global Tolvaptan API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Tolvaptan API Sales Quantity by Application (2018-2029)
  • 6.2 Global Tolvaptan API Consumption Value by Application (2018-2029)
  • 6.3 Global Tolvaptan API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Tolvaptan API Sales Quantity by Type (2018-2029)
  • 7.2 North America Tolvaptan API Sales Quantity by Application (2018-2029)
  • 7.3 North America Tolvaptan API Market Size by Country
    • 7.3.1 North America Tolvaptan API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Tolvaptan API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Tolvaptan API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Tolvaptan API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Tolvaptan API Market Size by Country
    • 8.3.1 Europe Tolvaptan API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Tolvaptan API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tolvaptan API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Tolvaptan API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Tolvaptan API Market Size by Region
    • 9.3.1 Asia-Pacific Tolvaptan API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Tolvaptan API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Tolvaptan API Sales Quantity by Type (2018-2029)
  • 10.2 South America Tolvaptan API Sales Quantity by Application (2018-2029)
  • 10.3 South America Tolvaptan API Market Size by Country
    • 10.3.1 South America Tolvaptan API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Tolvaptan API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tolvaptan API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Tolvaptan API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Tolvaptan API Market Size by Country
    • 11.3.1 Middle East & Africa Tolvaptan API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Tolvaptan API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Tolvaptan API Market Drivers
  • 12.2 Tolvaptan API Market Restraints
  • 12.3 Tolvaptan API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tolvaptan API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tolvaptan API
  • 13.3 Tolvaptan API Production Process
  • 13.4 Tolvaptan API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tolvaptan API Typical Distributors
  • 14.3 Tolvaptan API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Tolvaptan API. Industry analysis & Market Report on Tolvaptan API is a syndicated market report, published as Global Tolvaptan API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Tolvaptan API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,198.12
    		4,797.18
    		6,396.24
    		529,203.60
    		793,805.40
    		1,058,407.20
    		292,876.80
    		439,315.20
    		585,753.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo